(Acamprosate, Naltrexone, Disulfiram in AUD)

Repeat liver transaminases at 6 and 12 months and then every 12 months thereafter Efficacy and safety beyond 8 months is unclear; after 8 months, reassess patient regularly for adverse effects and need for continuation of therapy ................
................